Supplementary Figure 3: Nuclear YAP expression in BRAF- and RAS-mutant cancer cell lines.
From: The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Nuclear/cytoplasmic fractionation and immunoblot analysis of the indicated proteins in (a) BRAF V600E–mutant cancer cell lines and (b) RAS-mutant cancer cell lines. Data represent three independent experiments.
